Efficacy of Upadacitinib After NECS in Vitiligo — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy of Upadacitinib After NECS in Vitiligo — Stella

Recruiting

Back to Vitiligo trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Department of Dermatology and Venerology, The First Hospital of Jilin University, No. 1 Xinmin Street, Changchun, Jilin

Key details

Sponsor

Jilin University

Enrollment target

~60 participants

Started

December 2024

Primary completion

June 2026

Age range

18 Years – 60 Years

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov